Randomised, double-blind trial of carboplatin and paclitaxel with daily oral cediranib or placebo in patients with advanced non-small cell lung cancer: NCIC Clinical Trials Group study BR29 - European Journal of Cancer
Phase 3 Trial Comparing Nanoparticle Albumin-Bound Paclitaxel With Docetaxel for Previously Treated Advanced NSCLC - ScienceDirect
CLINICAL TRIALS [GANNET53]
Ongoing clinical trials investigating the addition of an anti-stroma... | Download Table
Efficacy and safety of first-line veliparib and carboplatin–paclitaxel in patients with HER2− advanced germline BRCA+ breast cancer: Subgroup analysis of a randomised clinical trial - European Journal of Cancer
nab-Paclitaxel as a potential partner with checkpoint inhibitors in so | OTT
Paclitaxel and Carboplatin for Carcinoma Clinical Trial | Power
Diagram of the study; clinical trial flow chart. A total of 100... | Download Scientific Diagram
Paclitaxel nanoformulations that are approved or in clinical trials for... | Download Scientific Diagram
Paclitaxel (Taxol) in breast cancer adjuvant therapy: chronology of... | Download Scientific Diagram
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial - The Lancet
PLOS ONE: A First-Time-In-Human Phase I Clinical Trial of Bispecific Antibody-Targeted, Paclitaxel-Packaged Bacterial Minicells
Nanoparticle Albumin-bound Paclitaxel Plus Carboplatin Induction Followed by Nanoparticle Albumin-bound Paclitaxel Maintenance in Squamous Non–Small-cell Lung Cancer (ABOUND.sqm): A Phase III Randomized Clinical Trial - Clinical Lung Cancer
Paclitaxel Poliglumex - an overview | ScienceDirect Topics
HER2 and Response to Paclitaxel in Node-Positive Breast Cancer | NEJM
PLOS ONE: A First-Time-In-Human Phase I Clinical Trial of Bispecific Antibody-Targeted, Paclitaxel-Packaged Bacterial Minicells
A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial - The Lancet
cisplatin and nab-paclitaxel for Biliary Tract Cancer Clinical Trial | Power
Comparison of Pivotal Clinical Trials of Paclitaxel Coated Balloons | CFR Journal
Immunotherapy as a treatment strategy in advanced stage and recurrent endometrial cancer: review of current phase III immunotherapy clinical trials - Ramez N. Eskander, Matthew A. Powell, 2021
A randomized phase III trial in patients with recurrent platinum sensitive ovarian cancer comparing efficacy and safety of paclitaxel micellar and Cremophor EL-paclitaxel - Gynecologic Oncology
CIRSE 2019: Hear the latest from clinical trials comparing paclitaxel technologies head-to-head - Vascular News
Efficacy and safety of carboplatin with nab-paclitaxel versus docetaxel in older patients with squamous non-small-cell lung cancer (CAPITAL): a randomised, multicentre, open-label, phase 3 trial - The Lancet Healthy Longevity
Frontiers | Targeting Strategies for Enhancing Paclitaxel Specificity in Chemotherapy | Cell and Developmental Biology
Clinical Trials Included in the Meta-Analysis | Download Table
Efficacy and safety of a novel paclitaxel-nano-coated balloon for femoropopliteal angioplasty: one-year results of the EffPac trial - EuroIntervention